Related Experiment Video

Updated: Mar 24, 2026

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells
08:47

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells

Published on: May 1, 2020

3.4K

Elevated Translation Initiation Factor eIF4E Is an Attractive Therapeutic Target in Multiple Myeloma

Shirong Li1, Jing Fu1, Caisheng Lu1

  • 1Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York.

Molecular Cancer Therapeutics
|March 5, 2016
PubMed

Insights

eukaryotic initiation factor 4E (eIF4E) is overexpressed in multiple myeloma and drives tumor growth by regulating oncogenic transcripts. Inhibiting eIF4E effectively blocks multiple myeloma progression, highlighting its therapeutic potential.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • eIF4E is a key regulator of protein translation, crucial for tumorigenesis.
  • eIF4E plays a critical role in the nuclear export and translation of oncogenic transcripts.
  • Inhibition of Exportin1 (XPO1), the main nuclear export protein for eIF4E-bound oncoprotein mRNAs, decreases tumor cell growth.

Purpose of the Study:

  • To investigate the role and therapeutic potential of eIF4E in multiple myeloma.
  • To determine if eIF4E is overexpressed in multiple myeloma cells.
  • To assess the impact of eIF4E modulation on multiple myeloma tumor progression.

Main Methods:

  • Compared eIF4E expression in myeloma cells versus normal plasma cells.
  • Utilized stable overexpression and knockdown of eIF4E in multiple myeloma models.
  • Employed a tet-on-inducible eIF4E-knockdown system in a human xenograft mouse model.
  • Analyzed the regulation of specific mRNAs (e.g., c-MYC, C/EBPβ) by eIF4E.

Main Results:

  • eIF4E is overexpressed in multiple myeloma cell lines and primary cells.
  • Overexpression of eIF4E significantly increases multiple myeloma tumorigenesis.
  • Knockdown of eIF4E impairs multiple myeloma tumor progression in vivo.
  • eIF4E downregulation blocks tumor growth, correlating with decreased eIF4E expression.
  • eIF4E regulates translation of specific mRNAs (c-MYC, C/EBPβ) crucial for proliferation in myeloma cells.

Conclusions:

  • eIF4E is critical for multiple myeloma cell proliferation and tumor progression.
  • eIF4E is an ideal and selective therapeutic target for multiple myeloma.
  • Targeting eIF4E can effectively block multiple myeloma cell growth.

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

903
Xenopus laevis as a Model to Identify Translation Impairment10:24

Xenopus laevis as a Model to Identify Translation Impairment

Published on: September 27, 2015

11.2K

Related Concept Videos

Initiation of Translation02:33

Initiation of Translation

Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
40.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
66
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
16
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
159.7K